دورية أكاديمية

[An update on the most recent mini-invasive surgical and interventional techniques in the management of benign prostatic obstruction].

التفاصيل البيبلوغرافية
العنوان: [An update on the most recent mini-invasive surgical and interventional techniques in the management of benign prostatic obstruction].
عنوان ترانسليتريتد: Mise au point sur les nouvelles techniques chirurgicales et interventionnelles dans la prise en charge de l’obstruction sous-vésicale liée à l’hyperplasie bénigne de la prostate.
المؤلفون: Wilisch J; Service d'urologie, hôpital privé Natecia, Lyon, France. Electronic address: jonas@wilisch.org., Pradere B; Service d'urologie, CHU Tours, Tours, France; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Autriche., Misrai V; Service d'urologie, clinique Pasteur, Toulouse, France., Baumert H; Service d'urologie, clinique de l'Alma, Paris, France., Doizi S; Service d'urologie, hôpital Thenon, Paris, France., Lebdai S; Service d'urologie, CHU Angers, Angers, France., Delongchamps NB; Service d'urologie, hôpital Cochin, Paris, France., Benchikh A; Service d'urologie, clinique les Martinets, Versailles, France., Negra ED; Service d'urologie, hôpital des Côtes d'Armor, Saint Brieuc, France., Fourmarier M; Service d'urologie, centre hospitalier du Pays d'Aix, Aix-en-Provence, France., Chevrot A; Service d'urologie, CHU Nimes, Nimes, France., Rouscoff Y; Service d'urologie, Polyclinique Saint-Georges, Nice, France., Theveniaud PE; Service d'urologie, CHR de Metz Thionville, Metz, France., Vincendeau S; Service d'urologie, CH, CHP Saint-Grégoire, Saint-Grégoire, France., Descazeaud A; Service d'urologie, CHU Limoges, Limoges, France., Gas J; Service d'urologie, CHU Toulouse, Toulouse, France., Robert G; Service d'urologie, CHU de Bordeaux, Bordeaux, France.
مؤلفون مشاركون: Comité des troubles mictionnels de l’homme de l’Association française d’urologie
المصدر: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie [Prog Urol] 2021 Apr; Vol. 31 (5), pp. 266-274. Date of Electronic Publication: 2020 Dec 25.
نوع المنشور: Journal Article; Review
اللغة: French
بيانات الدورية: Publisher: Progrès en urologie, S.A.R.L Country of Publication: France NLM ID: 9307844 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1166-7087 (Print) Linking ISSN: 11667087 NLM ISO Abbreviation: Prog Urol Subsets: MEDLINE
أسماء مطبوعة: Publication: Paris : Progrès en urologie, S.A.R.L
Original Publication: Paris : F.I.I.S.,
مواضيع طبية MeSH: Prostatic Hyperplasia/*surgery , Urethral Obstruction/*surgery, Humans ; Male ; Minimally Invasive Surgical Procedures ; Prostatectomy/methods ; Prostatic Hyperplasia/complications ; Urethral Obstruction/etiology
مستخلص: Introduction: New surgical techniques for the treatment of benign prostatic obstruction (BPO) have emerged in recent years. We sought to give an overview on each of these technologies.
Material: A comprehensive review of the literature between 2013 and 2020 was carried out by a panel of national experts already practicing these interventions. All the data were then discussed among all the co-authors in order to obtain a consensus with regard to the selected articles and their analysis. Finally, an inventory was drawn to provide an overview of these technological advances and their availability in France.
Results: The treatment benign prostatic obstruction has diversified greatly over the past 5 years. 5 new technologies have emerged, allowing today a transurethral non-ablative treatment (UROLIFT®, ITIND®), a transurethral ablative treatment (REZUM®), a transurethral ablative treatment with robotic assistance (AQUABEAM®) or an endovascular management by embolization of the prostatic arteries. Only UROLIFT® is considered an established technology in the latest EAU-Guidelines. The other four are under evaluation and recommendations have only been issued for two of them, AQUABEAM® and the embolization of the prostatic arteries.
Conclusion: These new minimally invasive techniques aim to increase the therapeutic options for the management of BPO in order to offer a management more suited to the wishes of the patient. Some are positioned as an alternative to surgical or medical treatment, others between medical and surgical treatment. These technologies are not all at the same level of development, evaluation and level of proof, but have in common a limited distribution in France, in particular given their cost. Validated studies will allow them to position their subsequent use more precisely.
(Copyright © 2020 Elsevier Masson SAS. All rights reserved.)
فهرسة مساهمة: Keywords: AQUABEAM®; BPH; Benign prostatic obstruction; Embolisation des artères prostatiques; Hyperplasie prostatique; ITIND®; Innovation; Nouvelles techniques; Prostatic artery embolization; Prostatic hyperplasia; REZUM®; Traitement; UROLIFT®
تواريخ الأحداث: Date Created: 20201228 Date Completed: 20210902 Latest Revision: 20210902
رمز التحديث: 20240628
DOI: 10.1016/j.purol.2020.12.001
PMID: 33358720
قاعدة البيانات: MEDLINE
الوصف
تدمد:1166-7087
DOI:10.1016/j.purol.2020.12.001